ADAPTIVE BIOTECHNOLOGIES (ADPT)
US00650F1093 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -225.30M | -200.40M | -207.30M | -146.20M | -68.60M | |||
| Depreciation Amortization | 22.23M | 20.90M | 14.00M | 8.50M | 7.80M | |||
| Change In Working Capital | -46.18M | -71.50M | -56.80M | -40.80M | 254.90M | |||
| Interest Paid | 8.98M | N/A | N/A | N/A | N/A | |||
| Other non cash items | 92.93M | 67.00M | 57.40M | 28.90M | 11.30M | |||
| OPERATING CASH FLOW | -156.32M | -183.90M | -192.70M | -149.70M | 205.40M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -10.70M | -16.30M | -61.70M | -18.80M | -11.20M | |||
| Other Investing Activity | 140.34M | 19.30M | 243.00M | -98.20M | -470.50M | |||
| INVESTING CASH FLOW | 129.65M | 2.90M | 181.20M | -117.00M | -481.70M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 2.25M | 7.90M | 26.70M | 293.90M | 324.90M | |||
| Other Financing Activity | 0.00 | 124.40M | 400.00K | -300.00K | -5.00M | |||
| FINANCING CASH FLOW | 2.25M | 132.30M | 27.10M | 293.60M | 319.90M | |||
| CHANGE IN CASH | -24.43M | -48.70M | 15.60M | 26.90M | 43.60M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -156.32M | -183.90M | -192.70M | -149.70M | 205.40M | |||
| Capital Expenditure | -10.70M | -16.30M | -61.70M | -18.80M | -11.20M | |||
| FREE CASH FLOW | -167.02M | -200.20M | -254.40M | -168.50M | 194.20M | |||
All data in USD